Kathleen Claes

14.2k total citations
124 papers, 3.5k citations indexed

About

Kathleen Claes is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Kathleen Claes has authored 124 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 48 papers in Genetics and 32 papers in Cancer Research. Recurrent topics in Kathleen Claes's work include BRCA gene mutations in cancer (30 papers), DNA Repair Mechanisms (22 papers) and CRISPR and Genetic Engineering (18 papers). Kathleen Claes is often cited by papers focused on BRCA gene mutations in cancer (30 papers), DNA Repair Mechanisms (22 papers) and CRISPR and Genetic Engineering (18 papers). Kathleen Claes collaborates with scholars based in Belgium, United States and United Kingdom. Kathleen Claes's co-authors include Bruce Poppe, Kim De Leeneer, Anne Vral, Ludwine Messiaen, Kim De Ruyck, Ilse Coene, Pieter Evenepoel, Yves Vanrenterghem, Bert Bammens and Leo De Ridder and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Kathleen Claes

116 papers receiving 3.4k citations

Peers

Countries citing papers authored by Kathleen Claes

Since Specialization

Citations

This map shows the geographic impact of Kathleen Claes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Claes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Claes more than expected).

Fields of papers citing papers by Kathleen Claes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Claes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Claes. The network helps show where Kathleen Claes may publish in the future.

Co-authorship network of co-authors of Kathleen Claes

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Claes. A scholar is included among the top collaborators of Kathleen Claes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Claes. Kathleen Claes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EMT ‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines 2025 ·Molecular Oncology ·Nele Vandenbussche, (unknown), Béatrice Lintermans, (unknown), Joachim Taminau, (unknown), Geert Berx, Kris Gevaert, Kathleen Claes	0
2	Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol 2025 ·BMC Surgery ·(unknown), (unknown), Wim Ceelen, (unknown), (unknown), (unknown), Nele Vandenbussche, Kathleen Claes, (unknown), (unknown), (unknown), Willem Lybaert, (unknown), (unknown), (unknown), (unknown), Christophe Beyls, Mark P.S. Sie, Frederik Berrevoet	0
3	Zebrafish Avatars: Toward Functional Precision Medicine in Low-Grade Serous Ovarian Cancer 2024 ·Cancers ·(unknown), Jan Willem Bek, (unknown), (unknown), Olivier De Wever, (unknown), Marta F Estrada, Jo Van Dorpe, Hannelore Denys, Koen Van de Vijver, Kathleen Claes	3
4	EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer 2024 ·European Journal of Human Genetics ·Trudi McDevitt, Miranda Durkie, Norbert Arnold, George J. Burghel, (unknown), Kathleen Claes, (unknown), Rachel Robinson, (unknown), (unknown), Helen Hanson, Clare Turnbull, Stacey Hume	5
5	HRAS ‐related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects 2023 ·Clinical Genetics ·Aude Beyens, (unknown), Kathleen Claes, Elfride De Baere, (unknown), (unknown), (unknown), Olivier Vanakker, Jan van der Meulen, Lieve Vanwalleghem, Bert Callewaert	1
6	The psychological impact of genetic testing in childhood cancer: A systematic review 2023 ·Psycho-Oncology ·(unknown), Kathleen Claes, Robin De Putter, Claire E. Wakefield, Marieke Van Schoors, Sabine Hellemans, Lesley Verhofstadt	7
7	Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer 2021 ·Scientific Reports ·Franceska Dedeurwaerdere, Kathleen Claes, Jo Van Dorpe, Isabelle Rottiers, Joni Van der Meulen, Joke Breyne, (unknown), Geert A. Martens	86
8	Missing heritability in Bloom syndrome: First report of a deep intronic variant leading to pseudo‐exon activation in the BLM gene 2020 ·Clinical Genetics ·(unknown), (unknown), Marieke De Bruyne, Simon J. Tavernier, (unknown), Bart N. Lambrecht, Filomeen Haerynck, Kathleen Claes	3
9	Atm deficient zebrafish model reveals conservation of the tumour suppressor function 2020 ·Ghent University Academic Bibliography (Ghent University) ·(unknown), (unknown), David Creytens, Jo Van Dorpe, Andy Willaert, Anne Vral, Kathleen Claes	2
10	Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy 2020 ·DNA repair ·(unknown), (unknown), Andy Willaert, Anne Vral, Kathleen Claes	5
11	Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2 -associated hereditary breast and ovarian cancer reveals multiple co-acting second hits 2018 ·Cancer Letters ·Mattias Van Heetvelde, Mieke Van Bockstal, Bruce Poppe, Kathleen Lambein, Toon Rosseel, Lilit Atanesyan, Dieter Deforce, Ivo Van Den Berghe, Kim De Leeneer, Jo Van Dorpe, Anne Vral, Kathleen Claes	12
12	Studying the functionality of the homologous repair pathway in zebrafish embryos : heading for an in vivo functional test to evaluate the pathogenicity of BRCA2 variants 2016 ·Ghent University Academic Bibliography (Ghent University) ·(unknown), Andy Willaert, Kris Vleminckx, Petra Vermassen, (unknown), Paul Coucke, Anne Vral, Kathleen Claes	1
13	Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li-Fraumeni syndrome and Cowden syndrome 2015 ·Jo Robays, Sabine Stordeur, (unknown), Tom Van Maerken, Kathleen Claes, Nicolas Janin, Gert Matthijs, (unknown), Martine Berlière, Hans Wildiers, Bruce Poppe	1
14	IRF6 Screening of Syndromic and a priori Non-Syndromic Cleft Lip and Palate Patients: Identification of a New Type of Minor VWS Sign 2012 ·Data Archiving and Networked Services (DANS) ·(unknown), Michella Ghassibe‐Sabbagh, Nicole Revençu, Odile Boute, Melissa Lees, (unknown), C. Verellen‐Dumoulin, Yves Sznajer, Kathleen Claes, Koenraad Devriendt, (unknown), Geert Mortier, Catheline Vilain, Geneviève Pierquin, C. Vincent‐Delorme, Y. Gillerot, R Vanwijck, Bénédicte Bayet, Miikka Vikkula	1
15	Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel Association 2009 ·Cancer Research ·Hilde Brems, Caroline Park, Ophélia Maertens, Alexander Pemov, Ludwine Messiaen, Meena Upadhyaya, Kathleen Claes, Eline Beert, Kristel Peeters, Victor Mautner, Jennifer L. Sloan, Lawrence Yao, Chyi‐Chia Richard Lee, Raf Sciot, Luc De Smet, Eric Legius, Douglas R. Stewart	92
16	Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association (vol 69, pg 7393, 2009) 2009 ·Ghent University Academic Bibliography (Ghent University) ·Hilde Brems, Caroline Park, Ophélia Maertens, Alexander Pemov, Ludwine Messiaen, Meena Upadhyaya, Kathleen Claes, Eline Beert, Kristel Peeters, Victor Mautner, Jennifer L. Sloan, Lawrence Yao, Chyi‐Chia Richard Lee, Raf Sciot, Luc De Smet, Eric Legius, Douglas R. Stewart	4
17	Prometheus versus MARS: Comparison of efficiency in two different liver detoxification devices 2005 ·Nephrology Dialysis Transplantation ·Pieter Evenepoel, Alexander Wilmer, Frederik Nevens, Kathleen Claes, Dirk Kuypers, Bart Maes, Bert Bammens, Wim Laleman, Yves Vanrenterghem	3
18	Comparison of dialysis efficiency in two different liver detoxification devices: MARS versus Prometheus 2005 ·Hepatology ·Pieter Evenepoel, Wim Laleman, Alexander Wilmer, Kathleen Claes, Dirk Kuypers, Bart Maes, Bert Bammens, Frederik Nevens, Yves Vanrenterghem	1
19	BRCA1/2 mutation spectrum and frequencies in Belgian breast/ovarian cancer families 2003 ·The American Journal of Human Genetics ·Kathleen Claes, Bruce Poppe, Ilse Coene, Anne De Paepe, Ludwine Messiaen	0
20	Identification and characterisation of a founder mutation in the Belgian breast/ovarian cancer population 2000 ·The American Journal of Human Genetics ·Kathleen Claes, Bruce Poppe, (unknown), Michel De Vos, (unknown), Ilse Coene, Anne De Paepe, Ludwine Messiaen	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact